Data / Form D filings / Pheast Therapeutics, Inc.
Pheast Therapeutics, Inc.: Form D filings
Pheast Therapeutics, Inc., a technology company in Redwood City, CA, filed 3 Form D notices with the SEC between 2022 and 2025. The latest, on October 16, 2025, reports $24.6 million sold of a $40 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 200 CARDINAL WAY, STE 300, Redwood City, CA, 94063
- Phone
- (650) 374-2223
- Industry
- Other Technology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1943737
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 16, 2025 | New notice | $39,999,993 | $24,588,083 | $15,411,910 | 7 | Oct 7, 2025 | sec.gov |
| Apr 10, 2025 | Amendment | $75,250,000 | $75,250,000 | 7 | Jan 31, 2022 | sec.gov | |
| Oct 28, 2022 | New notice | $75,250,000 | $25,224,698 | $50,025,302 | 7 | Jan 31, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Irving Weissman | Director | |
| Roy Maute | Executive Officer, Director | |
| Raphael Rousseau | Executive Officer | |
| Steven Gillis | Director | |
| Jacob Vogelstein | Director | |
| Amira Barkal | Director | |
| Thomas Marty | Executive Officer |
Other technology companies in California that filed recently
- OutLens, Inc. $32,000 · Nov 2, 2026
- ECFX, Inc. offering · Nov 2, 2026
- Redwagon Systems Inc. $1.2 million · Oct 30, 2026
- General Compute Inc. $132.2 million · Oct 30, 2026
- Promptiva Health Inc. offering · Oct 30, 2026
- thenevercompany.ai Inc. $200,000 · Oct 29, 2026
Every Form D from the week of Oct 13, 2025 · All recent filings in California · All recent Other Technology filings
Read from SEC EDGAR. Amount sold is what Pheast Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.